Faes Farma has acquired Laboratório Edol

Target Company Name:
Country:
Advisory:
Sector:
Partner:
Laboratório Edol
Portugal
Advisor to the buyer
Healthcare & Pharmaceuticals
Anquor Corporate Finance

Description: Portuguese pharmaceutical company that develops, manufactures, and markets medicines, medical devices, cosmetics, body‑care products, and dietary supplements—focusing on ophthalmology, dermatology, ENT, and dermocosmetics

Aquor Corporate Finance acted as the buy-side financial advisor in the transaction through which Faes Farma (Spain) acquired the Portuguese pharmaceutical laboratory Edol.
Laboratório Edol
Faes Farma
Faes Farma (Spain) acquires the Portuguese pharmaceutical laboratory Edol. Aquor Corporate Finance acted as the buy-side
logo
Advisor to the buyer :
Anquor Corporate Finance

Experts who worked on this transaction

Pascal Vieilledent

Pascal Vieilledent

Founder & CEO at Anquor Corporate Finance

Gonzague de Vial

Gonzague de Vial

Managing Director at Anquor Corporate Finance

Relevant transactions

Transactions
Akodoc
Corman
Acodok and Corman merged through an asset contribution into the newly established NewCo, ClickSalute
logo
Advisor :
Broletto Corporate Advisory
Otofarma
Otofarma has successfully completed its listing on the Euronext Growth Milan market
logo
Advisor :
Broletto Corporate Advisory
Cosmetic Surgery Group
Olympus Cosmetic Group
Cosmetic Surgery Group has partnered with Olympus Surgery Group, a portfolio company of VSS Capital Partners.
logo
Advisor to the seller :
Brown Gibbons Lang & Company
NordicLabs AS
Longship AS
Sale of NordicLabs (NordicNeuroLab & NordicImagingLab) to the Norway-based private equity fund Longship
logo
Advisor to the seller :
Saga Corporate Finance

REACH Cross-Border Mergers & Acquisitions is a worldwide partnership of 24 M&A advisory firms operating across 30 countries.

REACH Cross-Border Mergers & Acquisitions Logo with tagline Terms & Conditions
Privacy Policy

© 2026 REACH Cross-Border Mergers & Acquisitions